BioMap Announces 11 AI Life Science Collaborations

Nov 12, 2026
BioMap announced 11 collaborations covering drug research, agricultural breeding, biological modeling and international expansion.

BioMap announced collaborations with 11 organizations at its International Bio-Computing Innovation Summit 2026 in Hong Kong, the company said in a press release. The projects cover drug research, traditional Chinese medicine, agricultural breeding, biological modeling and international expansion.

BioMap and the University of Hong Kong will continue work on a model that simulates breast cancer cell functions. The company will also establish an AI traditional Chinese medicine laboratory with Hong Kong Baptist University and work with PepLib on peptide and cyclic peptide therapeutics.

Other projects include an AI breeding platform with Soy-Sky FarmTech, molecular point of care testing research with Coyote Bioscience and a virtual organism model with HiDream.ai. BioMap also plans an AI bio computing center in Singapore with Temasek Life Sciences Laboratory and an AI biomanufacturing laboratory with Revvity.

BioMap and Harbour BioMed will work through MegaStream TechBio on a closed loop workflow that connects computational research with laboratory experiments. BioMap will also explore research and commercial opportunities in Japan and other overseas markets with DEFTA Partners.

We hope you enjoyed this article

Free newsletter

Enterprise AI Brief

Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.